{"id":1016,"slug":"网上到处说的-存活率77-是哪来的数据-可信度怎么样","question":"网上到处说的「存活率77%」是哪来的数据？可信度怎么样？","intent":"informational","language":"zh","url":"https://worldwiki.io/q/网上到处说的-存活率77-是哪来的数据-可信度怎么样","entity":{"slug":"svf-breast-augmentation","name":"SVF Breast Augmentation","url":"https://worldwiki.io/entity/svf-breast-augmentation"},"answer":{"short_answer":"该数字出自韩国SC301机构自己发表在《Annals of Plastic Surgery》（2023）的384例单中心研究：左乳平均注入162.35 mL，保有率3个月78.65%、6个月77.17%、18个月77.48%（18个月随访n=102）。同一机构2020年的105例报告为1个月85.1%、3个月75.1%、6个月73.7%。这两篇都是经同行评审但由实施机构自身作者撰写、没有对照组的研究，因此只能视为该机构的自报结果，不等于行业平均水平。","detailed_answer":"<p>读这个数字时有三点要留心：一是<strong>测量部位</strong>——77.48%是左乳的测量值；二是<strong>随访流失</strong>——384例中随访到18个月的只有102例；三是<strong>无对照组</strong>，无法据此判断「加SVF比不加好多少」。<sup>[1]</sup></p><p>该机构还报告，注入脂肪干细胞数超过6000万的患者存活率为90.5%，低于6000万者为68.9%，并称SVF细胞数更多、乳房组织更柔软者保有率更高——这是该机构自己的结论，尚无独立研究验证。<sup>[2]</sup></p>","format":"paragraph","confidence":55,"verified_at":null,"updated_at":"2026-09-20 17:11:10"},"sources":[{"id":27,"title":"A Study on Breast Augmentation Using Fat Grafting With Stromal Vascular Fraction (Shin DJ, Ann Plast Surg 2023;90(4):380-384)","url":"https://pubmed.ncbi.nlm.nih.gov/36881737/","publisher":"Annals of Plastic Surgery","type":"academic","accessed_at":"2026-09-19 18:00:57"},{"id":28,"title":"Breast Augmentation by Fat Transplantation With Adipose-Derived Stem/Stromal Cells (Shin DJ, Aesthet Surg J Open Forum 2020)","url":"https://pubmed.ncbi.nlm.nih.gov/33791627/","publisher":"Aesthetic Surgery Journal Open Forum","type":"academic","accessed_at":"2026-09-19 18:00:58"}],"published_at":"2026-09-20 08:11:10"}